Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartwig Huland

Showing results (11-20 of 368) with videos related to

Pageof 37
Sort By:
Deutsches Arzteblatt International|September 4, 2013
Results of radical prostatectomy in newly diagnosed prostate cancer: long-term survival rates in locally advanced and high-risk cancersHendrik Isbarn, Hartwig Huland, Markus Graefen
European Urology|March 31, 2015
Centralization and Quality Control of Elective Surgery Improve Outcome: Aren't We Ethically Obliged to Force the Pace of Creating High-volume Centers?Derya Tilki, Hartwig Huland, Markus Graefen
European Urology|September 1, 2015
Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7Neil E Martin, Caleb Stowell, Hartwig Huland
European Urology|July 18, 2017
Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?Philipp Mandel, Markus Graefen, Hartwig Huland, et al.
European Urology|October 8, 2015
Detailed Quantification of High-grade Cancer Allows Precise Prediction of Prostate Cancer PrognosisMarkus Graefen, Thorsten Schlomm, Guido Sauter, et al.
Current Urology Reports|May 27, 2004
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancerAlexander Haese, Markus Graefen, Hartwig Huland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?Philipp Schriefer, Stefan Steurer, Hartwig Huland, et al.
Urologic Oncology|March 28, 2015
The effect of age on functional outcomes after radical prostatectomyPhilipp Mandel, Markus Graefen, Uwe Michl, et al.
Cancer|September 5, 2002
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinomaAlexander Haese, Jonathan I Epstein, Hartwig Huland, et al.
European Urology|March 27, 2007
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinomaMartin G Friedrich, Uwe Pichlmeier, Hartwig Schwaibold, et al.
Pageof 37

Showing results (11-20 of 368) with videos related to

Sort By:
Pageof 37
Deutsches Arzteblatt International|September 4, 2013
Results of radical prostatectomy in newly diagnosed prostate cancer: long-term survival rates in locally advanced and high-risk cancersHendrik Isbarn, Hartwig Huland, Markus Graefen
European Urology|March 31, 2015
Centralization and Quality Control of Elective Surgery Improve Outcome: Aren't We Ethically Obliged to Force the Pace of Creating High-volume Centers?Derya Tilki, Hartwig Huland, Markus Graefen
European Urology|September 1, 2015
Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7Neil E Martin, Caleb Stowell, Hartwig Huland
European Urology|July 18, 2017
Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?Philipp Mandel, Markus Graefen, Hartwig Huland, et al.
European Urology|October 8, 2015
Detailed Quantification of High-grade Cancer Allows Precise Prediction of Prostate Cancer PrognosisMarkus Graefen, Thorsten Schlomm, Guido Sauter, et al.
Current Urology Reports|May 27, 2004
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancerAlexander Haese, Markus Graefen, Hartwig Huland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?Philipp Schriefer, Stefan Steurer, Hartwig Huland, et al.
Urologic Oncology|March 28, 2015
The effect of age on functional outcomes after radical prostatectomyPhilipp Mandel, Markus Graefen, Uwe Michl, et al.
Cancer|September 5, 2002
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinomaAlexander Haese, Jonathan I Epstein, Hartwig Huland, et al.
European Urology|March 27, 2007
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinomaMartin G Friedrich, Uwe Pichlmeier, Hartwig Schwaibold, et al.
Pageof 37